IDO1 and cervical cancer: Meanwhile, IDO1 levels were mostly upregulated in cervical cancer specimens, and the survival rate of patients in the IDO1 high-expression group was lower than that in the IDO1 low-expression group within 2 years (Fig. 1c, d).